First patient dosed with ZI-MA4-1 in the ZIMA-101 Phase 1 trial at The Christie NHS Foundation TrustZI-MA4-1 is the world’s first MAGE-A4-targeting TCR-NK therapy in clinical developmentZIMA-101 ...
Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures, and ...
This repository contains the De-Identification of Medical Imaging Data: A Comprehensive Tool for Ensuring Patient Privacy, which enables users to anonymize a wide ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results